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Summary-It has been demonstrated that susceptibility to glucocorticoid-induced formation of cleft palate 
is regulated by the mouse histocompatibility complex (H-Z). This has encouraged us to examine H-Z 
effects on glucocorticoid binding in tissues of adult animals which would provide sufficient material with 
which to study the biochemical mechanism of the H-Zeffect. Although it has been reported that cytosol 
prepared from lungs of adult mice with a high susceptibility to steroid-induced cleft palate formation have 
a higher level of glucocorticoid binding than lung cytosol prepared from a low-susceptibility strain, we 
are unable to demonstrate any influence of H-Zon binding capacity in this tissue from adult animals when 
glucocorticoid receptors are assayed in the presence of receptor reducing and stabilizing agents that 
maximize binding capacity. 
Cytosol prepared from rat liver contains an endogenous receptor-reducing system composed of 
NADPH and thioredoxin. It has also been reported that the murine H-2 complex contains a gene(s) that 
regulates the level of a modifier(s) in fetal hepatic cytosol that affects the binding of glucocorticoids to 
the receptor. Of two known low molecular weight modifiers that could account for this effect, we have 
previously established that the heat-stable, steroid receptor “modulator” is not regulated by the H-2 
complex. In the present work we have assayed thioredoxin, a second potential modifier, in liver cytosols 
prepared from adults of two pairs of two H-2 congenic mouse strains. Our results show that the amount 
of thioredoxin is the same in all four mouse strains and that it is not regulated by the H-2 locus. 
At this time, we are unable to identify a system in adult mice in which the widely reported regulation 
of glucocorticoid binding by the mouse histocompatibility locus can be submitted to definitive biochemical 
study. 
INTRODUCTION 
Several years ago, it was established that various 
strains of hamsters exhibit different degrees of sus- 
ceptibility to glucocorticoid-induced cleft palate [l]. 
In mice, the different susceptibilities to 
glucocorticoid-induced cleft palate are partially con- 
trolled by the H-2locus, the major histocompatibility 
locus in this species [2,3]. Subsequently, it was 
reported [4] that facial mesenchyme cells cultured 
from fetuses of a mouse strain that is highly 
susceptible to glucocorticoid-induced cleft palate 
(A/J) have twice the specific glucocorticoid binding 
capacity as cells from a low susceptibility strain 
(C57BL/6J). Higher levels of specific glucocorticoid 
binding capacity have also been measured in fetal 
palatal tissue obtained from highly susceptible strains 
when compared to palatal tissue from less susceptible 
strains [5-71. Studies of binding capacity in congenic 
mouse strains that differ primarily at the H-Z locus 
have led to the proposal that glucocorticoid binding 
capacity, like glucocorticoid-induction of cleft palate, 
is regulated in part by the H-2 haplotype [5-71. 
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As mouse strains with defined H-2 haplotypes 
could prove to be powerful experimental tools with 
which to investigate the factors that control specific 
glucocorticoid binding capacity, we examined the 
effect of the H-Z locus on steroid binding capacity in 
mouse liver [8]. Mouse liver was chosen because it is 
a large organ that is a well characterized target of 
glucocorticoid action and because H-Zis expressed in 
liver [9]. Specific glucocorticoid binding capacity was 
assayed in liver cytosols prepared from four mouse 
strains: A/J (high susceptibility), C57BL/6J (low sus- 
ceptibility), and the two H-2congenic lines A.BY and 
BIO.A. We found that the level of specific glu- 
cocorticoid binding activity in liver cytosol is not 
mediated by the H-2 locus [8]. Katsumata et al. [7] 
have directly compared the glucocorticoid binding 
capacity of fetal palate and maternal liver in four 
mouse strains and found that the H-Z locus affects 
total specific glucocorticoid binding capacity in the 
former but not in the latter. 
Although the total glucocorticoid binding capacity 
in liver is not regulated by H-2, there is evidence that 
the H-2 complex contains a gene(s) that regulates the 
level of a modifier(s) in hepatic cytosol that affects the 
binding of glucocorticoids to the receptor. The evi- 
dence was obtained by Katsumata et al.[lO] who 
found that plots of dexamethasone binding versus 
concentration of fetal liver cytosol were linear for 
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C57BLjlO and BlO.A(SR) mice whereas similar bind- Livers and lungs were lightly blotted to remove excess 
ing plots for strains Bl0.A and BlO.A(2R) were not. liquid, weighed, and transferred to a prechilled ho- 
There are two low molecular weight modifiers that mogenizing vessel. All tissues were homogenized on 
could account for this H-Z effect in liver. One is a ice with a Teflon pestle in 1.5 ml of 10 mM Hepes 
heat-stable molecule that stabilizes the glucocorticoid buffer (pH 7.35) per gram of tissue. For some experi- 
binding capacity of cytosol preparations. This sta- ments the homogenizing buffer also contained 10 mM 
bilizing factor was originally reported by Cake et sodium molybdate, or 10 mM dithiothreitol, or both 
ul.[ 1 l] and has been called the “modulator” [12, 131. sodium molybdate and dithiothreitol. The homoge- 
We have developed an assay to quantitate this recep- nates were centrifuged at 27,000g for 20 min and the 
tor stabilizing factor [14] and have reported that the resulting supernatants were recentrifuged at 
level of its activity in mouse liver cytosol is not 100,OOOg for 2 h. The 100,OOOg supernatants are 
regulated by the H-2 locus [15]. A second modifier is referred to as cytosol preparations and were used for 
a cytosolic system that activates’ receptors from a all of the binding assays in this work. In some cases, 
nonsteroid-binding to a steroid-binding state [16-191. cytosols were stored at - 70°C until used. 
We have recently shown that this receptor activating Incubation conditions and steroid binding assay. 
system is a NADPH-dependent, thioredoxin- Each 100 ~1 assay contained 45 ~1 of cytosol, 45 ~1 of 
mediated reducing system that maintains the glu- Hepes buffer pH 7.35 (or buffer with additions of 
cocorticoid receptor in an appropriate steroid- dithiothreitol or molybdate or both as noted in the 
binding conformation [19]. In the work to be reported legends to the tables), and 50 nM [3H]triamcinolone 
in this paper we have examined whether this receptor acetonide in the presence or absence of a l,OOO-fold 
reducing system is regulated by the H-2 locus and excess of nonradioactive dexamethasone or vehicle. 
could account for the H-2 effects on glucocorticoid All samples were incubated overnight at 0°C prior to 
binding that have been reported in both liver and addition of 0.15 ml of a suspension containing 1% 
other tissues. charcoal (w/v) and 0.27: Dextran (w/v) in 10mM 
Hepes buffer, pH 7.35, to absorb free steroid. The 
MATERIALS AND METHODS charcoal-cytosol mixture was incubated for 10 min at 
Materials 
4°C and centrifuged at 12,OOOg for 5 min. Bound 
steroid was assayed by liquid scintillation counting of 
[6,7-iH]Triamcinolone acetonide’ (31.4 Ci/mmol) the supernatant fluid. The specific binding capacity 
was obtained from New England Nuclear, Boston, represents the average of duplicate assays made in the 
Massachusetts. Nonradioactive dexamethasone and absence of dexamethasone minus the nonspecific 
bovine insulin were from Sigma Chemical Co., St binding values and is expressed as fmoles per mg 
Louis, Missouri. Adult A/J (A background, H-Z”), cytosol protein. It should be noted that the values for 
A.BY/SnJ (A background, H-2*), C57BL/6J (B specific binding reported in this paper are somewhat 
background, H-2*), and BlO.A/SgSnJ (B back- lower than the values reported in our previous study 
ground, H-2”) mice were purchased originally from of glucocorticoid binding in mouse hepatic 
Jackson Laboratory and are bred and maintained in cytosol[8]. All of the calculations in the previous 
our mouse colony. All mice used in this study were study contain a constant error that had been intro- 
adult males. Purified Escherichia coli thioredoxin was duced into the calculating factor that was used to 
generously provided by Dr Vincent Pigiet in the convert from counts per minute of steroid bound to 
Department of Biochemistry, Johns Hopkins Univer- picomoles of steroid bound. The concentration of 
sity. [3H]triamcinolone acetonide used to assay glu- 
Methods 
cocorticoid binding capacity in this study (50 nM) is 
several times higher than the concentration required 
Preparation ofcytosols. Mice were killed by decap- to occupy all specific binding sites and is a rapid and 
itation and tissues were removed immediately and valid assay for the total binding activity of 
placed in ice cold Earle’s balanced salt solution. cytosol[20,21]. 
Assay for thioredoxin. Thioredoxin was assayed by 
‘The term “activation” will be used throughout this paper the insulin disulfide reduction method of 
to describe the process whereby the receptor is con- Holmgren [22]. Portions of the 100,000 g liver super- 
verted from a nonbinding form to a form that binds natants were boiled for 2min and centrifuged at 
steroids. We use the term”transformation” to describe 
the process whereby the steroid-bound receptor is 
12,000g for 5 min. The boiled supematants were 
converted to a form that binds to nuclei, DNA- 
lyophilized to dryness, dissolved in 1 ml of distilled 
cellulose. etc. water, and passed through a column of Sephadex 
‘The trivial names for steroids and abbreviations used are: G-25 (2.5 x 94 cm) using an elution buffer of 10 mM 
triamcinolone acetonide, 9a-fluoro-l18,16aJ7a,21- 
tetrahydroxypregna-1,4-diene-3,20,dione 16,17-aceton- 
Hepes; pH 7.35. The frakons containing the macro- 
ide; dexamethasone, 9a-fluoro-16a-methy1-11~,17a,21- 
molecular material (determined by A,,,) were pooled 
trihydroxypregna-1,4-diene-3,20-dione; Hepes, 4-(2- and concentrated again by lyophilization. The lyoph- 
hvdroxvethvlk1-knerazine-N’-2-ethanesulfonic acid: ilized material was redissolved in an amount of 
CTT, &thi%hrekdl. distilled water equivalent to one third of the volume 
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Table 1. Glucocorticoid binding capacity in cytosols prepared from livers and lungs of A/J and C57BL/6J mice 









plus DTT and 
Molybdate 
295 + 28 (10) 218 f 32(10) N.S. 17k8(7) 1 * 1 (7) N.S. 
506+46(10) 323 f 35 (10) 0.01 226*30(10) 294 * 38 (10) N.S. 
330 * 41 (10) 208?43(10) N.S. I5 * 9 (10) 13k4(10) N.S. 
562 + 65 (9) 437 f 20 (9) N.S. 260 + 27 (10) 348 + 50(11) N.S. 
Liver or lungs from the two strains of mice were homogenized in 10 mM Hepes buffer, in buffer plus 10 mM dithiothreitol 
(DTT), buffer plus IOmM sodium molybdate, or in buffer plus DTT and molybdate. Aliquots of each cytosol were 
incubated with [3H]triamcinolone acetonide and specific binding was determined as described under Methods. Each 
value represents the mean and standard error for the number of cytosol preparations noted in parentheses. P values 
were determined by Student’s l-test (two tailed). N.S. = not significant, P > 0.05. 
of the original boiled supernatant. An aliquot 
(50-100~1) of each test sample was incubated in a 
final volume of 0.6 ml in a 1 ml cuvette at room 
temperature with 500 ~1 of bovine insulin (1 mg/ml), 
8~1 of 50mM dithiothreitol, and the appropriate 
volume of 100mM phosphate buffer, pH 7.0, con- 
taining 2 mM EDTA. Measurements were performed 
at b5,, every 5-10min. Rates of insulin reduction 
were expressed as the change in turbidity with time 
observed between 0.02 and l.OA,,, above back- 
ground. The nonenzymatic reduction of insulin by 
dithiothreitol was recorded in a control cuvette 
without thioredoxin and this value (0.008 
A,,, nm x min-‘) was subtracted from that recorded 
with each test sample to yield the rate of insulin 
reduction due to thioredoxin. A standard curve for 
the assay was prepared with purified Escherichia coli 
thioredoxin and the amount of thioredoxin is ex- 
pressed as nmoles per mg of original cytosol protein. 
RESULTS AND DISCUSSION 
The steroid binding capacity of glucocorticoid 
receptors in cytosol preparations is considerably 
more labile than that of other steroid receptors. The 
rapidity of receptor inactivation varies according to 
the tissue from which the cytosol is prepared. In the 
rat, for example, receptors in liver cytosol are quite 
stable, whereas receptors in thymocyte cytosol are 
relatively labile, and those in lung cytosol are com- 
pletely inactivated during the time of cytosol 
preparation [16-191. To obtain maximum glu- 
cocorticoid binding capacity in cytosols from most 
rat tissues, it is necessary to have both a sulfhydryl 
reducing agent, such as dithiothreitol, and a receptor 
stabilizing agent, such as molybdate, present during 
tissue homogenization and centrifugation [23]. If cy- 
tosols are prepared in the absence of molybdate, then 
one assays only the binding capacity remaining at the 
time of steroid addition. In particularly labile cyto- 
sols, such as cytosol prepared from lung tissue, the 
number of receptor sites that are assayed may repre- 
sent only a small fraction of the total possible number 
of binding sites in the preparation. When one is trying 
to establish strain-specific or tissue-specific 
differences in the number of glucocorticoid receptors, 
it is clearly important that assays be carried out under 
conditions that maximize binding capacity. 
The experiment of Table 1 shows the effect of 
adding receptor-reducing and stabilizing agents to the 
buffers used for homogenizing livers and lungs from 
two mouse strains. These two organs were chosen for 
this study because: (1) They provide enough tissue 
mass to permit biochemical characterization of any 
observed strain differences in binding; (2) H-2 regu- 
lation of glucocorticoid binding has been reported in 
fetal mouse hepatic cytosol [lo]; and (3) It has 
recently been reported that glucocorticoid receptor 
levels are significantly higher in cytosols prepared 
from lungs of adult mice with the H-2” haplotype 
(Bl0.A) than in a strain with the H-2b haplotype 
(strain BlO, which differs from BI0.A within the if-2 
complex only) [24]. In both of these cases, glu- 
cocorticoid binding capacity was assayed in cytosols 
lacking reducing agents. If the H-2 haplotype deter- 
mines a real 2-fold difference in the number of 
receptors in lung cytosols, then this difference should 
also be observed when glucocorticoid binding capac- 
ity is maximized by the presence of dithiothreitol and 
molybdate. In the experiments presented in Table 1 
we have assayed the binding in cytosols prepared 
from lungs of A/J mice which have the H-2” hap- 
lotype and from C57BL/6J which have the H-2b 
haplotype (Fig. 1). It is clear that no significant 
difference was found in binding capacity between the 
two strains, either in the absence or presence of 
additions. 
The relatively low levels of specific glucocorticoid 
binding that have been reported [24] in lung cytosols 
prepared from B 10.A and BIO mice (62 and 
31 fmol/mg protein, respectively) probably do not 
represent the total binding capacity of the tissue. The 
glucocorticoid binding levels that we have observed 
in lung cytosol in the absence of reducing and 
stabilizing agents are so low that comparisons be- 
tween strains would be meaningless. We have, how- 
ever, prepared lung cytosols from the two congenic 
lines A.BY and Bl0.A using buffer containing dith- 
iothreitol and molybdate. A.BY has the H-2b region 
of the C57 strain placed on the A genetic back- 
ground, while B1O.A has the C57 background but the 
A/J H-2’ region. As shown in Table 2, there is no 
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217 k-2K c4 H-2D 
i ’ \ / 1 
m-j i I I 
14 03 22 
Strain Alleles at loci 
Glo- 1 H-2u c4 ii-2D 
A/J a k d d 
BIO.A a k d d 
C57BL16 a b b b 
A.BYSn a b b b 
Fig. I. Partial genetic map of genes on chromosome I? in 
the H-2 region of four congenic mouse strains. Data shown 
in Fig. 1 has been compiled from Klein et al. [28]. The mouse 
strains A/J and BIO.A are designated H-2 haplotype a, while 
strains C57BL/6 and A.BYSn are designated H-2 haplotype 
b. Beneath the chromosome diagram, the letters a, b, k and 
d represent alleles for the following genes: giyoxylase-1 
(Glo-I), complement component 4 (C4), histocompatibility- 
2K (H-2K) and histocompatibility-2D (H-2D). The num- 
bers shown are approximate distances between the indicated 
loci in centimorgans. The centromere is indicated by the 
symbol (c), 
relationship between H-2 haplotype and specific 
binding capacity under these assay conditions. It is 
possibie that the H-2 related difference reported for 
lung cytosols in the absence of reducing and sta- 
bilizing agents reflects a genetically-determined 
difference in endogenous r~eptor-reducing capacity. 
Such a difference could explain both the difference in 
binding capacity reported in mouse lung cytosols [24] 
and the existence of an H-2 regulated modifier of 
glucocorticoid binding reported in mouse liver 
cytosols [lo]. 
Rat liver cytosol contains an endogenous, heat- 
stable glucocorticoid receptor-reducing system com- 
posed of NADPH and thioredoxin [19]. the glu- 
cocorticoid binding capacity of cytosol prepared 
from different rat tissues in the absence of dith- 
iothreitol varies according to the activity of the 
Table 2. Relationship of specific gluc~orti~id-binding ca- 
pacity of lung cytosols to H-2 and genetic background 
Haplotype 
Background H-2” H-2 
A/J A.BY 
A 26Ok27 380 i: 59 
(JO) (6) 
BIO.A C57BL/bJ 
B 390 + 51 348 4 50 
(6) (11) 
Lungs obtained from four strains of mice were homogenized 
in 10mM Hepes buffer, pH 7.35, with 1OmM dith- 
inthreitol and IOmM sodium molybdate. Aliquots of 
each cytosol preparation were incubated with 
[‘H]triamcinolone acetonide to determine the specific 
binding capacity as described under Methods. Glu- 
cocorticoid binding data is presented as fmoles steroid 
bound per mg of liver cytosoi protein. Each value 
represents the mean and standard error for the number 
of cytosol preparations noted in parentheses. Analysis of 
variance revealed no significant difference among the 
groups (F = 1.27, Fo9< = 2.93, FO,r = 1.45). 
Table 3. Relationship of thioredoxin concentration in liver 
cytosois to H-2 and genetic backgorund 
Haplotype 
Background U-2” H-Zh .._ .-. ~ ~ - 
A/J A.BY-. 
A 1.37 2 0.29 1.70+0.30 
(9) (21 
BIO.A C57BLi6J 
B 1.94 i 0.06 1.43 io.14 
(2) (8) 
Thioredoxin levels were determined by the insulin disulfide 
reduction assay described in detail under Methods. The 
thioredoxin levels are expressed in nmoIes per mg of liver 
cytosoi protein, and the values represent the mean and 
standard error for the number of cytosol preparations 
noted in parentheses. Analysis of variance revealed no 
significant difference among the groups (F =0.50. 
F,,, = 3.20, F,,,s = i.SO). 
endogenous reducing system [19]. Of four rat tissues 
that we have examined (liver, lung, spleen, thymus), 
the highest binding capacity, the highest endogenous 
receptor-activating activity, and the highest NADPH 
and thioredoxin levels were found in liver cytosol, 
whereas the lowest levels of all four activities were 
found in cytosol from lung 1191. As shown in Table 
1, the glucocorticoid binding capacity of mouse liver 
cytosol is not highly sensitive to the addition of 
dithiothreitol. The relative stability of liver cytosol 
binding capacity is reflected in its substantial thio- 
redoxin content. It is clear from the data of Table 3, 
however, that the thioredoxin content is similar in 
cytosols prepared from two pairs of two congenic 
mouse strains and that variations in the H-2 locus do 
not regulate thioredoxin content. The levels of thio- 
redoxin in mouse lung are not presented because they 
were below the sensitivity of the assay. The level of 
thioredoxin we have assayed in rat Iung cytosol is 
somewhat higher than that of mouse but it is still only 
about 15% of that assayed in rat liver [19]. 
At this time, we feel that it is appropriate to 
reappraise the relationship between ~ucocorticoid 
binding capacity and the mouse histocompatibility 
locus. Several observations can be made that are 
useful to investigators who are interested in studying 
the biochemical mechanisms that determine the 
steroid-binding conformation, the stability, and the 
amount of glucocorticoid receptors. First, several 
laboratories have reported a higher glucocorticoid 
binding capacity in palatal cells of fetal mice ex- 
hibiting a high susceptibility to glucocorticoid- 
induced cleft palate (A/J) than in strains with low 
susceptibility (C57BL/6J and others) [4-71. In one 
comprehensive study of triamcinolone acetonide 
binding in tissue from whole heads or paiate- 
containing head sections of fetal mice, however, no 
correlation could be established between glu- 
cocorticoid binding capacity and cleft palate 
s~~eptibility f25J. Differences between laboratories 
may reflect the time at which fetal tissue was ob- 
tained. It has been reported that differences in glu- 
cocorticoid binding activity between A/J and 
C57BL/6J embryos which can be observed on day 11 
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have disappeared by day 13 or 14 of gestation[I6J. 
Any differences in glucocorticoid binding capacity 
that are regulated by the H-2 locus are not deter- 
mined by expression of the structural gene for the 
glucocorticoid receptor protein, as that gene is lo- 
cated on chromosome 18, not with the H-2 locus on 
chromosome 17 1271. If the H-Z complex contains a 
gene(s) that regulates the level of a modifier(s) that 
affects the binding of glucocorticoid to its receptor 
in liver cytosol [lo], then that modifier is not either 
the steroid receptor “modulator” [ 151 or thioredoxin 
(Table 3). When specific glucoco~coid binding ca- 
pacity is measured in the presence of reducing equiv- 
alents, there is no H-Z-determined difference in bind- 
ing in adult mouse lung cytosols (Tables 1 and 2). No 
H-2 related difference in glucocorticoid binding ca- 
pacity has been observed in cytosols prepared from 
mouse liver [7,8J. Thus, there does not seem to be an 
adult mouse tissue where there is both clear H-2 
regulation of glucocorticoid binding capacity and 
sufficient tissue mass to permit the biochem~ca1 char- 
acterization of a strain difference. 
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